You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNLI Sale Disclosure
Chin Peter Scott · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$36.87K
Chin Peter Scott Chief Medical Officer
DNLI
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
DNLI daily price context
Close on/before transaction
$22.28
Sep 4, 2026
First close after public filing
$21.4
Sep 10, 2026
30-day return after filing
-9.11%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,654 shares @ $22.29
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002124755-26-000007
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$36.87K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Denali Therapeutics Inc. DNLI Current | Sale | Sep 4, 2026 | $36.87K |